GB1010254A - 4-amino-6,7-di(lower alkoxy) quinolines and derivatives thereof - Google Patents
4-amino-6,7-di(lower alkoxy) quinolines and derivatives thereofInfo
- Publication number
- GB1010254A GB1010254A GB38781/63A GB3878163A GB1010254A GB 1010254 A GB1010254 A GB 1010254A GB 38781/63 A GB38781/63 A GB 38781/63A GB 3878163 A GB3878163 A GB 3878163A GB 1010254 A GB1010254 A GB 1010254A
- Authority
- GB
- United Kingdom
- Prior art keywords
- lower alkyl
- amino
- hydrochloride
- group
- lower alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000003545 alkoxy group Chemical group 0.000 title abstract 2
- 150000003248 quinolines Chemical class 0.000 title abstract 2
- 229940111121 antirheumatic drug quinolines Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- -1 carbethoxymethyl Chemical group 0.000 abstract 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 abstract 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- PQLZPEOUMIHSFX-UHFFFAOYSA-N 2-[acetamido-[2-(3-methoxypropylamino)ethyl]amino]-2-(cyclohexylamino)-2-(pentylamino)acetic acid Chemical compound CCCCCNC(C(=O)O)(NC1CCCCC1)N(CCNCCCOC)NC(=O)C PQLZPEOUMIHSFX-UHFFFAOYSA-N 0.000 abstract 1
- KNDOFJFSHZCKGT-UHFFFAOYSA-N 4-chloroquinoline Chemical compound C1=CC=C2C(Cl)=CC=NC2=C1 KNDOFJFSHZCKGT-UHFFFAOYSA-N 0.000 abstract 1
- MEKBKSDSRNKXHH-UHFFFAOYSA-N 6,7-diethoxyquinolin-4-amine hydrochloride Chemical compound Cl.NC1=CC=NC2=CC(=C(C=C12)OCC)OCC MEKBKSDSRNKXHH-UHFFFAOYSA-N 0.000 abstract 1
- VQOOOFICIMKBGW-UHFFFAOYSA-N 6,7-dimethoxyquinoline;hydrochloride Chemical class Cl.C1=CN=C2C=C(OC)C(OC)=CC2=C1 VQOOOFICIMKBGW-UHFFFAOYSA-N 0.000 abstract 1
- 241000220479 Acacia Species 0.000 abstract 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229920001615 Tragacanth Polymers 0.000 abstract 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 239000000674 adrenergic antagonist Substances 0.000 abstract 1
- 239000000783 alginic acid Substances 0.000 abstract 1
- 235000010443 alginic acid Nutrition 0.000 abstract 1
- 229920000615 alginic acid Polymers 0.000 abstract 1
- 229960001126 alginic acid Drugs 0.000 abstract 1
- 150000004781 alginic acids Chemical class 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 239000007900 aqueous suspension Substances 0.000 abstract 1
- 239000000305 astragalus gummifer gum Substances 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- 239000001506 calcium phosphate Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 abstract 1
- 229940038472 dicalcium phosphate Drugs 0.000 abstract 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 abstract 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US242646A US3272824A (en) | 1962-12-06 | 1962-12-06 | 4-amino-6, 7-di(lower) alkoxyquinolines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1010254A true GB1010254A (en) | 1965-11-17 |
Family
ID=22915626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB38781/63A Expired GB1010254A (en) | 1962-12-06 | 1963-10-02 | 4-amino-6,7-di(lower alkoxy) quinolines and derivatives thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3272824A (en:Method) |
| AT (1) | AT248437B (en:Method) |
| BE (1) | BE640817A (en:Method) |
| BR (1) | BR6355254D0 (en:Method) |
| CH (1) | CH439290A (en:Method) |
| DK (1) | DK107024C (en:Method) |
| ES (1) | ES292176A1 (en:Method) |
| FI (1) | FI41554B (en:Method) |
| GB (1) | GB1010254A (en:Method) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0100200A1 (en) * | 1982-07-24 | 1984-02-08 | Pfizer Limited | 2-Substituted 4-amino-6,7-dimethoxyquinolines |
| EP0277625A3 (en) * | 1987-02-05 | 1990-07-11 | Hoechst-Roussel Pharmaceuticals Incorporated | Tetrahydropyrido[3',4':4,5]pyrrolo[2,3-c]quinolines, intermediates and a process for the preparation thereof and their use as hypotensive agents |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1035777A (en) * | 1963-08-20 | 1966-07-13 | Bellon Labor Sa Roger | Isoquinoline derivatives |
| FR6103M (en:Method) * | 1967-02-22 | 1968-06-10 | ||
| US3502681A (en) * | 1968-04-10 | 1970-03-24 | Roussel Uclaf | 7- or 8-chloro-4-phenylamino-chloroquinolines |
| US3668207A (en) * | 1970-01-22 | 1972-06-06 | Ciba Geigy Corp | 2-amino-4-aryl-quinolines |
| US3856796A (en) * | 1972-04-19 | 1974-12-24 | Sandoz Ag | Hydroxyalkyl-substituted-amino-quinolines and nitrates thereof |
| US4035367A (en) * | 1974-09-09 | 1977-07-12 | Sandoz, Inc. | Hydroxyalkyl-substituted-amino-quinolines |
| USRE37650E1 (en) | 1991-05-10 | 2002-04-09 | Aventis Pharmacetical Products, Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| US5480883A (en) * | 1991-05-10 | 1996-01-02 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| US5714493A (en) * | 1991-05-10 | 1998-02-03 | Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| JPH05213884A (ja) * | 1991-06-14 | 1993-08-24 | Upjohn Co:The | 新規な４−アミノキノリン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤 |
| NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
| IL128994A (en) * | 1996-09-25 | 2004-12-15 | Zeneca Ltd | History of quinoline and naphthyridine and their salts, processes for their preparation, pharmaceutical preparations containing them and their use as medicines |
| US6159978A (en) | 1997-05-28 | 2000-12-12 | Aventis Pharmaceuticals Product, Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| US6245760B1 (en) | 1997-05-28 | 2001-06-12 | Aventis Pharmaceuticals Products, Inc | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| US6180632B1 (en) | 1997-05-28 | 2001-01-30 | Aventis Pharmaceuticals Products Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| WO2002094789A1 (en) * | 2001-05-21 | 2002-11-28 | F. Hoffmann-La Roche Ag | Quinoline derivatives as ligands for the neuropeptide y receptor |
| US6787558B2 (en) * | 2001-09-28 | 2004-09-07 | Hoffmann-La Roche Inc. | Quinoline derivatives |
| US20070197538A1 (en) * | 2004-10-07 | 2007-08-23 | Mark Nesbit | Anti-vascular and anti-proliferation methods, therapies, and combinations employing specific tyrosine kinase inhibitors |
| CN108473435A (zh) | 2015-10-05 | 2018-08-31 | 纽约市哥伦比亚大学理事会 | 自噬潮和磷脂酶d的活化剂以及包括tau的蛋白聚集体的清除和蛋白质病的治疗 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2555943A (en) * | 1947-06-28 | 1951-06-05 | Sterling Drug Inc | Dihalo-4-(aliphatic tertiaryamino-alkylamino)quinolines |
| US2940976A (en) * | 1957-06-19 | 1960-06-14 | Sterling Drug Inc | 1-(lower-alkyl)-4-(quaternary-ammonium-alkylimino)-1, 4-dihydroquinolines |
| US2940974A (en) * | 1957-06-19 | 1960-06-14 | Sterling Drug Inc | 1-substituted-4-[(tertiary-or secondary-amino)-alkylimino]-1, 4-dihydroquinolines |
| US3002001A (en) * | 1958-04-03 | 1961-09-26 | Sterling Drug Inc | 4-alkylimino-1-[aromatic-(lower - alkyl)]-1,4-dihydroquinolines and their preparation |
-
1962
- 1962-12-06 US US242646A patent/US3272824A/en not_active Expired - Lifetime
-
1963
- 1963-10-02 GB GB38781/63A patent/GB1010254A/en not_active Expired
- 1963-10-03 ES ES292176A patent/ES292176A1/es not_active Expired
- 1963-11-29 DK DK559363AA patent/DK107024C/da active
- 1963-12-04 BE BE640817A patent/BE640817A/xx unknown
- 1963-12-04 FI FI2401/63A patent/FI41554B/fi active
- 1963-12-05 CH CH1498063A patent/CH439290A/de unknown
- 1963-12-06 AT AT977363A patent/AT248437B/de active
- 1963-12-06 BR BR155254/63A patent/BR6355254D0/pt unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0100200A1 (en) * | 1982-07-24 | 1984-02-08 | Pfizer Limited | 2-Substituted 4-amino-6,7-dimethoxyquinolines |
| EP0277625A3 (en) * | 1987-02-05 | 1990-07-11 | Hoechst-Roussel Pharmaceuticals Incorporated | Tetrahydropyrido[3',4':4,5]pyrrolo[2,3-c]quinolines, intermediates and a process for the preparation thereof and their use as hypotensive agents |
Also Published As
| Publication number | Publication date |
|---|---|
| US3272824A (en) | 1966-09-13 |
| BR6355254D0 (pt) | 1973-07-19 |
| DK107024C (da) | 1967-04-17 |
| CH439290A (de) | 1967-07-15 |
| AT248437B (de) | 1966-07-25 |
| ES292176A1 (es) | 1964-02-16 |
| BE640817A (en:Method) | 1964-04-01 |
| FI41554B (en:Method) | 1969-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1010254A (en) | 4-amino-6,7-di(lower alkoxy) quinolines and derivatives thereof | |
| IL65222A0 (en) | Dihydropyridine derivatives,their production and pharmaceutical compositions containing them | |
| GB1309835A (en) | Trialkoxy-quinazolines | |
| FI862757A0 (fi) | Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa. | |
| ES8503666A1 (es) | Procedimiento para la preparacion de 1-ariloxi-2,3,4,5-tetrahidro-3-benzazepinas | |
| GB1287659A (en) | Pyrimidinylpyrazole derivatives | |
| NO158578C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater. | |
| ES8502688A1 (es) | Procedimiento para preparar derivados de quinolina | |
| US2681910A (en) | Halogenated quinolinol compounds | |
| AR008375A1 (es) | Compuestos fluorenonas alquiloxiaminas sustituidas y derivados de los mismos, procedimiento para la preparacion de compuestos utiles como intermediarios en la preparacion de los mismos y compuestos intermediarios. | |
| DE68921719D1 (de) | Amphotericin B Derivate. | |
| NO923824L (no) | Bruk av trinitrobenzener eller karminsyre ved behandling av kreft eller virussykdommer | |
| GB1342321A (en) | Nitrofuran derivatives | |
| ES2070154T3 (es) | Derivados de piridoindol y procedimientos para su preparacion. | |
| GB2007656A (en) | 4-amino-2-(piperazin-1-yl or homopiperazin-1-yl) quinazoline derivatives | |
| GB1167711A (en) | Diarylcyclopropane Derivatives | |
| GB1008470A (en) | New cyanacetamide derivatives | |
| GB1500734A (en) | Phenoxyalkylamines and their preparation | |
| ES374947A1 (es) | Un procedimiento para la preparacion de derivados de dihi- drotriazina n-sustituida simetrica. | |
| ES350752A1 (es) | Un procedimiento de preparacion de nuevas cloroquinoleinas. | |
| GB990887A (en) | Carbamic acid derivatives | |
| GB1070736A (en) | Improvements in or relating to pyrido[3,4-b]indoles and the manufacture thereof | |
| GB970597A (en) | Therapeutic compositions containing n-substituted 4-aralkyl-piperidines | |
| GB1221407A (en) | 0,2,3,4-tetrahydro-7-substituted-6-sulfamyl-4-quinazolinones, process for preparing the same and pharmaceutical compositions comprising the same | |
| GB1180249A (en) | Quinoxaline Compounds, their preparation and Compositions containing them |